Yu-fei Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting of Gpx8-CSF1 axis resets the immune milieu of lung tumor and overcomes resistance to anti-PD-1 therapy.
Journal: Cell death and differentiation
Published: July 15, 2025
Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells.
Journal: Acta pharmacologica Sinica
Published: August 01, 2023
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer.
Journal: Science translational medicine
Published: October 06, 2021
NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells.
Journal: Acta pharmacologica Sinica
Published: January 15, 2020
Development and validation of a rapid, robust and sensitive UPLC-QQQ-MS/MS method for simultaneous quantification of GSH metabolism in lung cancer cells.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: November 15, 2019
UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: November 08, 2018
Polyunsaturated fatty acid intake and risk of lung cancer: a meta-analysis of prospective studies.
Journal: PloS one
Published: December 29, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026